Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04730362Completed
Randomised, double-blind trial (2 arms), sponsored by National Cancer Institute. Primary endpoint: Image quality of each MRI sequence. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04730362.